Counselors in South Deerfield, MA Accepting Medicare
5 Counselors found. Showing 1 - 5
 Ms. Heather Ann Skutnik-sheffield, M.A. LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 235 Greenfield Rd, South Deerfield, MA 01373 Phone: 413-453-9199 |
Mrs. Holly Nicole Majkut, LMHC, ATR-BC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 235 Greenfield Rd, Clinical Art Associates, Llc, South Deerfield, MA 01373 Phone: 413-665-2110 |
Dr. Leslie R. Abrams Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 235 Greenfield Rd, South Deerfield, MA 01373 Phone: 413-665-2110 |
Jessica King, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 110 N Hillside Rd Ste 21, South Deerfield, MA 01373 Phone: 413-350-1018 |
 Mark Biagini, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 235 Greenfield Rd, South Deerfield, MA 01373 Phone: 413-455-0768 |
News Archive
New DNA-based nanomachines can be used for gene therapy of cancer
Scientists from ITMO in collaboration with their international colleagues proposed new DNA-based nanomachines that can be used for gene therapy of cancer.
New ACP policy offers strategies to reduce firearms-related violence, injuries and deaths in the US
A new policy paper from the American College of Physicians offers nine strategies to address the societal, health care, and regulatory barriers to reducing firearms-related violence, injuries, and deaths in the United States. Reducing Firearm-Related Injuries and Deaths in the United States is published today in the peer-reviewed medical journal, Annals of Internal Medicine.
CPEX Pharmaceuticals initiates reviewing strategic alternatives to maximize shareholder value
CPEX Pharmaceuticals, Inc. today announced that its Board of Directors is continuing its previously announced process to review strategic alternatives to maximize shareholder value. The strategic alternatives the Board of Directors is reviewing include, but are not limited to, a sale, merger or other business combination of CPEX with a third party or a monetization of CPEX's assets including its rights to receive royalties and milestone payments.
Accelrys introduces new Cheminformatics Suite
Accelrys, Inc., a leading scientific enterprise R&D software and services company, today announced the new Accelrys Cheminformatics Suite, providing R&D organizations with the most robust, end-to-end solution available to register, search, mine and analyze information on chemical structures and reactions, chemically modified sequences and associated data such as inventory, assay and analytical results.
› Verified 5 days ago